Quote | Super Quote
Future News

02/10/2026 09:29

Innovent Biologics and WuXi AppTec drop 4%, biotech stocks open lower as northbound investors take holiday

  <Economic Information Daily News, Oct 2> Biotech stocks opened lower collectively. Innovent Biologics (01801) fell 3.9%, to HK$94.2; WuXi AppTec (02359) dropped 3.9%, to HK$206.8; China Biologic Products (01177) declined 1.8%, to HK$5.605; JD Health (06618) fell 6.9%, to HK$33.5, becoming the current blue-chip stock with the largest decline.

  Northbound funds are on holiday from today to the 7th due to the National Day holiday. Prior to the long holiday, northbound investors had taken the opportunity to buy heavily, causing the biotech sector to rise against the market trend on Wednesday (30th). However, with U.S. bond risks continuing to escalate, the biotech sector saw profit-taking right at market open today. The biotech sector is currently down over 3.7%, at 16,024 points, with 28 out of the 30 constituent stocks of the biotech index in decline.

  Currently, the Hang Seng Index stands at 23,967, down 645 points or 2.6%, with turnover on the main board nearing HK$14.3 billion. The Hang Seng China Enterprises Index is at 8,023, down 196 points or 2.4%. The Hang Seng Tech Index is at 4,145, down 108 points or 2.5%. (am)
 
Table showing performance of stocks in the same sector or related stocks
Stock (Code)Current Price (HK$)Change (%)
Innovent Biologics (01801)94.2Down 3.93%
WuXi AppTec (02359)206.8Down 3.9%
China Biologic Products (01177)5.605Down 1.84%
JD Health (06618)33.5Down 6.94%
BeiGene (06160)212.6Down 5.68%
GenScript Biotech (01548)43.52Down 2.99%
WuXi Biologics (02269)55.05Down 1.78%
Insilico Medicine (03696)57Down 5.16%
CSH Group (01093)9.955Down 1.14%
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.